Get the Stockscreener App
1.21
5.22%
0.06
After Hours:
1.22
0.01
+0.83%
Oragenics Inc stock is traded at $1.21, with a volume of 235.28K.
It is up +5.22% in the last 24 hours and up +3.42% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.15
Open:
$1.1
24h Volume:
235.28K
Relative Volume:
0.51
Market Cap:
$4.99M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1417
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
+12.04%
1M Performance:
+3.42%
6M Performance:
-85.85%
1Y Performance:
-91.93%
1-Day Range:
$1.10
$1.25
1-Week Range:
$1.10
$1.25
52-Week Range:
$1.01
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.21 | 4.68M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Stock (OGEN) Latest News
Is Oragenics Inc. stock reversal real or fake2025 Earnings Surprises & AI Driven Price Predictions - Newser
What’s next for Oragenics Inc. stock priceMarket Trend Report & Weekly Market Pulse Alerts - Newser
Oragenics Inc. stock trend outlook and recovery pathJuly 2025 Breakouts & Weekly High Return Opportunities - Newser
Oragenics Inc. recovery potential after sell offPrice Action & Precise Trade Entry Recommendations - Newser
Applying big data sentiment scoring on Oragenics Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - Newser
Leading vs lagging indicators on Oragenics Inc. performanceJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
What moving averages say about Oragenics Inc.July 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-12 05:07:15 - Newser
Published on: 2025-09-12 00:01:02 - Newser
What does recent volatility data suggest for Oragenics Inc.2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
Real time alert setup for Oragenics Inc. performance2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Will Oragenics Inc. price bounce be sustainableJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Reversal indicators forming on Oragenics Inc. stockGap Up & Weekly Setup with High ROI Potential - Newser
Top chart patterns to watch in Oragenics Inc.July 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
What technical models suggest about Oragenics Inc.’s comebackJuly 2025 Reactions & Real-Time Stock Movement Alerts - Newser
Price momentum metrics for Oragenics Inc. explainedWeekly Stock Summary & Community Driven Trade Alerts - Newser
What Fibonacci levels say about Oragenics Inc. rebound2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Using Ichimoku Cloud for Oragenics Inc. technicals2025 Momentum Check & Low Risk High Win Rate Picks - Newser
Key resistance and support levels for Oragenics Inc.2025 Earnings Impact & Real-Time Volume Analysis Alerts - Newser
How sentiment analysis helps forecast Oragenics Inc.Trade Performance Summary & Long-Term Capital Growth Ideas - Newser
AI Tools Suggest Oragenics Inc. May Outperform This Week2025 Earnings Impact & Fast Exit and Entry Trade Guides - beatles.ru
Published on: 2025-09-09 01:14:20 - Newser
Applying chart zones and confluence areas to Oragenics Inc.2025 Historical Comparison & Daily Entry Point Trade Alerts - Newser
Oragenics Inc. stock momentum explainedQuarterly Portfolio Review & Consistent Growth Equity Picks - Newser
RSI and MACD Indicate Shift in Oragenics Inc. SentimentWeekly Risk Summary & Real-Time Buy Signal Alerts - beatles.ru
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):